197 Novel FcyR recombinant fusion facilitates antibody arming of engineered iPSC-derived NK cells to enhance targeting and killing of ovarian cancer cells

Kristin Snyder; Kate Dixon; Melissa Khaw; Zachary Davis; Paul Rogers; Martin Hosking; Ryan Bjordahl; Bahram Valamehr; Jianming Wu; Bruce Walcheck

doi:10.1136/jitc-2021-SITC2021.197

Article info

Regular and Young Investigator Award Abstracts

Cellular Therapies

197 Novel FcyR recombinant fusion facilitates antibody arming of engineered iPSC-derived NK cells to enhance targeting and killing of ovarian cancer cells

Free

Authors

Kristin Snyder University of Minnesota, College of Veterinary Medicine, Saint Paul, MN, USA PubMed articles Google scholar articles
Kate Dixon University of Minnesota, College of Veterinary Medicine, Saint Paul, MN, USA PubMed articles Google scholar articles
Melissa Khaw University of Minnesota, Minneapolis, MN, USA PubMed articles Google scholar articles
Zachary Davis University of Minnesota, Minneapolis, MN, USA PubMed articles Google scholar articles
Paul Rogers Fate Therapeutics, San Diego, CA, USA PubMed articles Google scholar articles
Martin Hosking Fate Therapeutics, San Diego, CA, USA PubMed articles Google scholar articles
Ryan Bjordahl Fate Therapeutics, San Diego, CA, USA PubMed articles Google scholar articles
Bahram Valamehr Fate Therapeutics, San Diego, CA, USA PubMed articles Google scholar articles
Jianming Wu University of Minnesota, College of Veterinary Medicine, Saint Paul, MN, USA PubMed articles Google scholar articles
Bruce Walcheck University of Minnesota, College of Veterinary Medicine, Saint Paul, MN, USA PubMed articles Google scholar articles

Citation

Snyder K, Dixon K, Khaw M, et al

197 Novel FcyR recombinant fusion facilitates antibody arming of engineered iPSC-derived NK cells to enhance targeting and killing of ovarian cancer cells

Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-SITC2021.197

Publication history

First published November 10, 2021.

Online issue publication

November 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password